Cargando…
Long-term Results after CT-Guided Percutaneous Ethanol Ablation for the Treatment of Hyperfunctioning Adrenal Disorders
OBJECTIVES: To evaluate the safety and long-term efficacy of computed tomography-guided percutaneous ethanol ablation for benign primary and secondary hyperfunctioning adrenal disorders. METHOD: We retrospectively evaluated the long-term results of nine patients treated with computed tomography-guid...
Autores principales: | Frenk, Nathan Elie, Sebastianes, Fernando, Lerario, Antonio Marcondes, Fragoso, Maria Candida Barisson Villares, Mendonca, Berenice Bilharinho, de Menezes, Marcos Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054768/ https://www.ncbi.nlm.nih.gov/pubmed/27759849 http://dx.doi.org/10.6061/clinics/2016(10)08 |
Ejemplares similares
-
SUN-172 A False Positive Result in Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in a Girl with Beckwith Wiedemann Syndrome
por: Braga, Barbara Leitao, et al.
Publicado: (2020) -
An Overview of the Heterogeneous Causes of Cushing Syndrome Resulting From Primary Macronodular Adrenal Hyperplasia (PMAH)
por: Charchar, Helaine Laiz Silva, et al.
Publicado: (2022) -
Treatment of hyperfunctioning thyroid nodules by percutaneous ethanol injection
por: Larijani, Bagher, et al.
Publicado: (2002) -
POD-1/TCF21 Reduces SHP Expression, Affecting LRH-1 Regulation and Cell Cycle Balance in Adrenocortical and Hepatocarcinoma Tumor Cells
por: França, Monica Malheiros, et al.
Publicado: (2015) -
Genotype analysis of the human endostatin variant p.D104N in benign and malignant adrenocortical tumors
por: de Paula Mariani, Beatriz Marinho, et al.
Publicado: (2012)